Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock

NCT05402553 is registered in ClinicalTrials.gov with Noha Mansour as lead sponsor.

NCT NCT05402553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
Lead sponsor
Noha Mansour
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 24, 2022
Completion date
June 30, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock